BIOMAT Database Logo BIOMAT Database Logo

Effect of dipyridamole on proteinuria of diabetic nephropathy. 1983

H Makino, and S Okada, and Z Ota

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Makino, and S Okada, and Z Ota
Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
January 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
H Makino, and S Okada, and Z Ota
Effect of indomethacin on the proteinuria of diabetic nephropathy.
August 1984, The Journal of the Association of Physicians of India,
H Makino, and S Okada, and Z Ota
Effect of antihypertensive (captopril) treatment on proteinuria in diabetic nephropathy.
January 1988, Therapia Hungarica (English edition),
H Makino, and S Okada, and Z Ota
[Effect of antihypertensive (captopril) therapy on proteinuria in diabetic nephropathy].
April 1987, Orvosi hetilap,
H Makino, and S Okada, and Z Ota
Nephroprotective role of dipyridamole in diabetic nephropathy: Effect on inflammation and apoptosis.
December 2015, Life sciences,
H Makino, and S Okada, and Z Ota
The proteinuria of diabetic nephropathy.
December 1980, Clinica chimica acta; international journal of clinical chemistry,
H Makino, and S Okada, and Z Ota
Effect of dipyridamole on proteinuria of nephrotic syndrome.
March 1981, Lancet (London, England),
H Makino, and S Okada, and Z Ota
Diabetic nephropathy: the proteinuria hypothesis.
January 2005, American journal of nephrology,
H Makino, and S Okada, and Z Ota
Effect of direct renin inhibitor monotherapy on proteinuria in overt diabetic nephropathy.
January 2012, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
H Makino, and S Okada, and Z Ota
Suppression of proteinuria by dipyridamole in rats with aminonucleoside nephropathy.
January 1984, Renal physiology,
Copied contents to your clipboard!